• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Gene therapy for cancer using the gone gun system

Research Project

Project/Area Number 09557094
Research Category

Grant-in-Aid for Scientific Research (B)

Allocation TypeSingle-year Grants
Section展開研究
Research Field General surgery
Research InstitutionTohoku University

Principal Investigator

SUNAMURA Makoto  Tohoku University, Hospital, Lecture, 医学部附属病院, 講師 (10201584)

Co-Investigator(Kenkyū-buntansha) SHIBUYA Kazuhiko  Tohoku University, Hospital, Research Associate, 医学部附属病院, 助手 (70260429)
HAMADA Hirofumi  Sapporo Medical College, Medicine, Professor, 医学部, 教授 (00189614)
SATO Masaaki  Tohoku University, Engineering, Professor, 大学院・工学研究科, 教授 (30111371)
SHIMAMURA Hiromune  Tohoku University, Hospital, Research Associate, 医学部附属病院, 助手 (70312585)
江川 新一  東北大学, 医学部・附属病院, 助手 (00270679)
小針 雅男  東北大学, 医学部, 講師 (30170369)
Project Period (FY) 1997 – 1999
Project Status Completed (Fiscal Year 1999)
Budget Amount *help
¥11,800,000 (Direct Cost: ¥11,800,000)
Fiscal Year 1999: ¥3,000,000 (Direct Cost: ¥3,000,000)
Fiscal Year 1998: ¥3,100,000 (Direct Cost: ¥3,100,000)
Fiscal Year 1997: ¥5,700,000 (Direct Cost: ¥5,700,000)
Keywordsgene gun / gene therapy / cancer / angiogenesis / IL-12 / 遺伝子治療 / 腫瘍血管新生 / 抗腫瘍免疫 / BAI-1 / 腫瘍免疫 / 細胞死 / P53 / 遺伝子統 / 抗腫瘍療法
Research Abstract

In order to establish a gene therapy system without vectors, we checked the efficacy of gene gun for gene transduction. Although we could confirm the expression of LacZ gene in pancreatic cancer cells, the transduction efficacy was very low. It is important to choose the suitable gene which can express the efficient anti-tumor effect with low concentration for gene gun System. As an anti-tumor agent, Interleukin-12 has been revealed to be a key regulator of the immune response, particularly that involving CTL and NK cells. We report herein the anti-angiogenesis effect of IL-12 on human as well as murine tumors in NK-depleted SCID mice using fibroblasts genetically engineered to secrete this cytokine. Although the in vitro growth of tumor cells was not affected by the presence of IL-12, co-inoculation of IL-12 secreting fibroblasts strongly inhibited tumor growth in immunodeficient mice. The neovascularization surrounding the tumor was remarkably inhibited in the area where the IL-12 secreting fibroblasts were implanted, resulting in the suppression of tumor growth. Lectin staining in tumor sample sections also showed a significant reduction in the number of vessels. The RNA expression of IFN-γ and its inducible antiangiogenic chemokine IP-10 was stimulated in endothelial cells cultured with IL-12. It was also found that IL-12 downregulated the expression of the endothelial cell mitogens VEGF and bFGF.The anti-tumor effects of IL-12 were accompanied by interesting histological changes consisting of a high degree of keratinization and apoptosis and a decrease in the proliferation rate of human tumors and extensive necrosis in the murine ones. Therefore, IL-12 is the candidate gene for this gene gun system.

Report

(4 results)
  • 1999 Annual Research Report   Final Research Report Summary
  • 1998 Annual Research Report
  • 1997 Annual Research Report
  • Research Products

    (22 results)

All Other

All Publications (22 results)

  • [Publications] Matsumoto G: "Adjuvant immuretherapy using genetically engineered interleukin 12 secreting fibroblast prevent recurrence after surgical resection of established tumors ---"Surgery. 125. 257-264 (1999)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Lozonshi L: "Controlling tumor angiogenesis and metastasis of C26 murine colon adenocarcinoma by a new matrix metalloproteinase inhibitor"Cancer Researoh. 59. 1252-1258 (1999)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Duda D.G.: "Direct in vitro evidence and in vivo analysis of the antiangiogenesis effects of interlenkin 12"Cancer Research. 60. 1111-1116 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Sunamura M: "The anti-angiogenesis effect of IL-12 during early growth of human pancreatic cancer in SCID mice"Pancreas. 20. 227-233 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Yatsuoka T: "Association of pour prognosis and loss of 12g, 17g and 18g and concordant loss of 6g/17p and 12g/18g ---"American Journal of gastroenterolosy. 95. 2080-2085 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Sunamura M: "Restricted Replication-Competent adenovirus i a novel strategy for Cancer gene therapy"International Journal of Clinical Oncology. 5. 147-152 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Mori, Y., Matsunaga, M., Abe, T., Fukushige, S., Miura, K., Sunamura M., Shiiba, K., Nukiwa, T., Sato, M., Horii, A.: "Chromosome band 16q24 is frequently deleted in human gastric cancer."Br.J.Cancer. 80. 556-562 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Matsumoto G., Sunamura M., Shimamura H., Kodama T., Hashimoto W., Kobari M., Kato K., Takeda K., Yagita H., Okumura K., Hamada H., Matsuno S.: "Adjuvant immunotherapy using genetically engineered interleukin 12 secreting fibroblasts prevents recurrence after surgical resection of established tumors in a murine adenocarcinoma model."Surgery. 125. 257-264 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Lozonschi L., Sunamura M., Kobari M., Egawa S., Ding L., Matsuno S.: "Controlling tumor angiogenesis and metastasis of C26 murin colon adenocarcinoma by a new matrix metalloproteinase inhibitor, KB-R7785, in two tumor models."Cancer Res. 59. 1252-1258 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Yatsuoka T., Furukawa T., Abe T., Yokoyama T., Sunamura M., Kobari M., Matsuno S., Horii A.: "Genomic Analysis of the Thymine-DNA Glycosylase (TDG) Gene on 12q22-q24.1 in Human Pancreatic Ductal Adenocarcinoma."Int J Pancreatology. 25. 97-102 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Abe T., Makino N., Furukawa T., Ouyang H., Kimura M., Yatsuoka T., Yokoyama T., Inoue H., Fukushige S., Hoshi M., Hayashi Y., Sunamura M., Kobari M., Matsuno S.Horii A.: "Identification of three commonly deleted regions on chromosome arm 6q in human pancreatic cancer."Genes Chromosom. Cancer. 25. 60-64 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Kobari M., Egawa S., Shibuya K., Shimamura H., Sunamura M., Takeda K., Matsuno S.: "Intraductal papillary mucinous tumors of the pancreas comprise 2 clinical subtypes."Archives of Surgery. 134. 1131-1136 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Furukawa, T., Youssef, E.M.., Yatsuoka, T., Yokoyama, T., Makino, N., Inoue, H., Fukushige, S., Hoshi, M., Hayashi. Y., Sunamura M., and Horii, A.: "Cloning and characterization of the human UDP-N-acetylglucosamine : a-1, 3-D-mannoside b-1, 4-N-acetylglucosaminyltransferase IV-homologue (GnT-IV-H) gene."J Hum Genet. 44. 394-401 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Motoi F., Sunamura M., Ding L., Yoshida Y., Matsuno S., Hamada H.: "Effective gene therapy for pancreatic cancer by cytokines mediated by restricted replication-competent adenovirus."Hum Gene Ther. 11. 223-235 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Kobari M, Egawa S, Shibuya K, Sunamura M., Saitoh K., Matsuno S: "Effect of intraportal adoptive immunotherapy on liver metastases after resection of pancreatic cancer."Br J Surg. 87. 43-48 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Duda DG., Sunamura M., Lozonschi L., Kodama T., Egawa S., matsumoto G., Shimamura H., Shibuya K., Takeda K., Matsuno S.: "Direct in vitro evidence and in vivo analysis of the antiangiogenesis effects of interleukin 12."Cancer Research. 60. 1111-1116 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Sunamura M.: "Mutant adenoviruses selectively replication-competent in tumor cells. In Habib N.eds. Cancer gene thderapy-Past achievements and future challenges."Plenum Publishing Company Ltd, London : Adv Exp Med Biol 2000. 465. 65-71

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Sunamura M., Sun L., Lozonschi L., Duda D.G., Kodama T., Matsumoto G., Shimamura H., Takeda K., Kobari M., Hamada H., Matsuno S.: "The anti-angiogenesis effect of IL-12 during early growth of human pancreatic cancer in SCID mice."Pancreas. 20. 227-233 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Yatsuoka T., Sunamura M., Kimura M., Egawa S., Furukawa T.. Fukushige S., Abe T., Yokoyama T., Inoue H., Shibuya K., Takeda K., Kobari M., Matsuno S., Horii A.: "Association of poor prognosis and loss of 12q, 17q, and 18q and concordant loss of 6q/17p and 12q/18q in human pancreatic ductal adenocarcinoma."Am J Gastroenterol.. 95. 2080-2085 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Sunamura M., Motoi, F., Matsuno S.: "Restricted Replication-Competent Adenovirus : a Novel Strategy for Cancer Gene Therapy."Int J Clin Oncol. 5. 147-152 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Matsumoto G.,Sunamura M.,Shimamra H.: "Adjuvant immunotherapy using genetically engineered interleukrn 12 secreting fibroblasts prevents recurrence after surgical resection of established tumors in amurine adenocarcionma model"Surgery125. 125. 257-264 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] Duda DC,Sunamura M.,Lozonschi L.: "Direct in evidence and in vinvo analysis of anti-angiogenesis effects of interleukin 12"Cancer Reserch 60. 60. 111-116 (2000)

    • Related Report
      1999 Annual Research Report

URL: 

Published: 1997-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi